Nanomedicines continue to accelerate the forefront of drug delivery technologies. Inorganic mesoporous silica nanoparticles are a driving force with their unique and superlative properties. Recently, formulation researches with mesoporous silica nanoparticles have advanced many drug delivery systems, including liposome, microsphere, oro-dispersible film, 3D-printed formulation, and microneedle. 

Dipy Vasa from Pfizer focuses this talk on mesoporus silica solubility-enabling technology background and examples, her teams current work, experimental setup, controlling drug release with HPMCAS and potential applications to this approach.